Bacteria that can make testosterone: What could that mean for prostate cancer?

Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects. Now, scientists have identified an unexpected participant in androgen chemistry: a bacterium from the human urinary tract that can convert the steroid precursor DHEA into testosterone under laboratory conditions.

The finding does not mean that the bacterium causes prostate cancer, nor does it show that testosterone produced by bacteria reaches tumors or changes the course of disease. It does, however, reveal a previously unknown microbial route to a hormone that is central to prostate biology, raising new questions about whether the microorganisms living near the prostate could help shape its chemical environment.

Published in Nature Communications, the study brought together experts in microbiology, cancer biology, chemistry, genomics and computational physics. Researchers in Auburn University’s Department of Physics contributed computational structural biology that helped explain, at the atomic level, how the newly discovered bacterial machinery works.

Sign up for Blog Updates